Curative Biotechnology Inc (CUBT) — Cash Flow Quality Index
Curative Biotechnology Inc (CUBT) has a Cash Flow Quality Index of -0.04x as of March 2020. Operating cash flow of $-14.53K is below net income of $363.64K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Curative Biotechnology Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Curative Biotechnology Inc Cash Flow Quality Index (2015–2019)
Historical Cash Flow Quality Index for Curative Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Curative Biotechnology Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Curative Biotechnology Inc (2015–2019)
Year-by-year earnings quality comparison for Curative Biotechnology Inc. For live market cap and the full company financial profile, see CUBT company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $-150.00 | $331.95K | ▼ -104.4% |
| 2015 | 0.01x | $1.96K | $190.84K | — |